(Q34806351)

English

Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

author name string

Wim J van Blitterswijk

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Marcel Verheij

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Current Pharmaceutical Design

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

2061-2074

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M302674200

Identifiers

10.2174/138161208785294636

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34806351&oldid=2042328379"